NEW YORK, Dec. 26 – Compugen, an Israeli bioinformatics company that trades on the Nasdaq stock exchange, said Wednesday that it had received approval to list its shares on the Tel Aviv Stock Exchange.

The move towards a dual listing is aimed at increasing interest in Compugen’s stock by providing easier access for investors in Israel to trade the company’s shares.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.